Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Döring

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Medical Microbiology : IJMM|October 14, 2010
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patientsGerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 18, 2012
Eradication of Pseudomonas aeruginosa by early antibiotic treatment has been one of the major advances in the last decade for subjects with CF. IntroductionGerd Döring
Expert Review of Vaccines|March 3, 2012
Vaccine development for patients with cystic fibrosisGerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Early intervention and prevention of lung disease in cystic fibrosis: a European consensusGerd Döring, Niels Hoiby,
Cellular Microbiology|December 11, 2008
Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung diseaseGerd Döring, Erich Gulbins
Lancet (London, England)|February 28, 2003
Cystic fibrosisFelix Ratjen, Gerd Döring
Jornal De Pediatria|February 12, 2008
Osteoporosis in cystic fibrosisGerd Döring, Steven P Conway
Vaccine|February 5, 2008
Vaccines and immunotherapy against Pseudomonas aeruginosaGerd Döring, Gerald B Pier
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2007
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patientsGerd Döring, Christoph Meisner, Martin Stern, et al.
Pediatric Pulmonology|November 8, 2002
To the editor: adverse effects of ceftazidime treatmentGerd Döring, Harry G M Heijerman
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Medical Microbiology : IJMM|October 14, 2010
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patientsGerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 18, 2012
Eradication of Pseudomonas aeruginosa by early antibiotic treatment has been one of the major advances in the last decade for subjects with CF. IntroductionGerd Döring
Expert Review of Vaccines|March 3, 2012
Vaccine development for patients with cystic fibrosisGerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Early intervention and prevention of lung disease in cystic fibrosis: a European consensusGerd Döring, Niels Hoiby,
Cellular Microbiology|December 11, 2008
Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung diseaseGerd Döring, Erich Gulbins
Lancet (London, England)|February 28, 2003
Cystic fibrosisFelix Ratjen, Gerd Döring
Jornal De Pediatria|February 12, 2008
Osteoporosis in cystic fibrosisGerd Döring, Steven P Conway
Vaccine|February 5, 2008
Vaccines and immunotherapy against Pseudomonas aeruginosaGerd Döring, Gerald B Pier
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2007
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patientsGerd Döring, Christoph Meisner, Martin Stern, et al.
Pediatric Pulmonology|November 8, 2002
To the editor: adverse effects of ceftazidime treatmentGerd Döring, Harry G M Heijerman
Pageof 7